<structure><name> MCS </name>
<variables>
  <var><name> MCSF </name></var>
</variables>

<equations>
<!--
 <diffeq>
  <name> MacCell </name>  
     <integralname> MacCell </integralname>
     <initialval> 10000000 </initialval>
     <dervname> Change </dervname>
     <errorlim> 1000 </errorlim>
 </diffeq>

<diffeq>
  <name> PBMNC </name>  peripheral blood mononuclear cells
     <integralname> PBMNC </integralname>
     <initialval> 10000000 </initialval>
     <dervname> Change </dervname>
     <errorlim> 1000 </errorlim>
 </diffeq>



-->
</equations>

<definitions>
<block><name> Dervs </name>
  
 <!-- <def><name> MCSF </name><val> MCSF.MCSF </val></def>-->
</block>
</definitions>

</structure>

<!--
  1. low conc (1-100 pg/mL) TGFbeta stimulates mac cell generation:  stimulation of ERK pathway
      high conc (.1 ng/mL) inhibits formation:  stimulation of p38 MAPK
         (refs 159-162 in "TGFbeta1 to the bone"

  2. high levels of TGFbeta1 present in initial part of culture period vastly increase RANKL/MCSF induced 
      mac cell formation and bone resorption in lymphocyte rich population (endosteal surface) 
      in a lymphocyte poor or pure monocyte pop, clast formation was only somewhat enhanced by tgfbeta
          (refs 91,168 in "TGFbeta1 to the bone")

  3.  when TGFbeta1 is applied for the entire culture period (28d) or applied later in diff, the effect levels out
         (ref 91 in tgfbeta1 to the bone)

  4. upreg of RANK expression in pure pops of oc precursors by tgfbeta1 (ref 172, 174 in tgfbeta1 to the bone) 
      NB: no blast precursors means no OPG, so this effectmight even out in vivo


-->